HighPoint Advisor Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,118
| Closed | -$779K | – | 498 |
|
|
2019
Q3 | $779K | Sell |
7,118
-954
| -12% | -$90.6K | 0.17% | 108 |
|
|
2019
Q2 | $722K | Sell |
8,072
-64
| -0.8% | -$6.08K | 0.17% | 104 |
|
|
2019
Q1 | $776K | Sell |
8,136
-357
| -4% | -$31.2K | 0.19% | 109 |
|
|
2018
Q4 | $770K | Sell |
8,493
-628
| -7% | -$46.4K | 0.2% | 112 |
|
|
2018
Q3 | $735K | Buy |
9,121
+29
| +0.3% | +$2.56K | 0.2% | 123 |
|
|
2018
Q2 | $820K | Buy |
9,092
+25
| +0.3% | +$2.08K | 0.22% | 119 |
|
|
2018
Q1 | $717K | Sell |
9,067
-403
| -4% | -$38.7K | 0.2% | 134 |
|
|
2017
Q4 | $871K | Sell |
9,470
-646
| -6% | -$72.9K | 0.25% | 98 |
|
|
2017
Q3 | $993K | Buy |
10,116
+93
| +0.9% | +$12.7K | 0.31% | 81 |
|
|
2017
Q2 | $1.37M | Hold |
10,023
| – | – | 0.44% | 52 |
|
|
2017
Q1 | $1.37M | Buy |
10,023
+194
| +2% | +$23.2K | 0.44% | 52 |
|
|
2016
Q4 | $1.22M | Sell |
9,829
-181
| -2% | -$20.2K | 0.39% | 62 |
|
|
2016
Q3 | $1.22M | Sell |
10,010
-315
| -3% | -$34.1K | 0.43% | 58 |
|
|
2016
Q2 | $1.18M | Buy |
10,325
+8,005
| +345% | +$828K | 0.41% | 63 |
|
|
2016
Q1 | $256K | Sell |
2,320
-5,950
| -72% | -$613K | 0.16% | 153 |
|
|
2015
Q4 | $900K | Sell |
8,270
-812
| -9% | -$93.9K | 0.59% | 47 |
|
|
2015
Q3 | $982K | Sell |
9,082
-1,377
| -13% | -$171K | 1.09% | 22 |
|
|
2015
Q2 | $1.21M | Buy |
+10,459
| New | +$1.2M | 1.87% | 18 |
|
Other funds holding CELG
HighPoint Advisor Group's CELG Position: Q4 2019 in Review
HighPoint Advisor Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,118 shares — an estimated $779K sold.
HighPoint Advisor Group first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $1.37M in Q2 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- HighPoint Advisor Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- HighPoint Advisor Group sold 7,118 Celgene Corp shares in Q4 2019, an estimated $779K.
- HighPoint Advisor Group first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
- HighPoint Advisor Group's Celgene Corp position peaked at $1.37M in Q2 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on HighPoint Advisor Group's 13F filing for Q4 2019, filed 13 Feb 2020.